Cranial hypertrophic pachymeningitis with myelodysplastic syndrome.

Hypertrophic pachymeningitis Myelodysplastic syndrome Steroids therapy

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
30 Jun 2024
Historique:
received: 21 09 2023
revised: 12 06 2024
accepted: 12 06 2024
medline: 11 7 2024
pubmed: 11 7 2024
entrez: 11 7 2024
Statut: epublish

Résumé

Hypertrophic pachymeningitis (HP) is a rare inflammatory disease characterized by thickening of the dura mater. HP develops with several inflammatory diseases. Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis and IgG4 related disease are reported as 2 major causes. With hematologic diseases, only 3 cases have been reported. We report the case of myelodysplastic syndrome (MDS) developing HP. Our case provides a thought-provoking hypothesis regarding the potential relationship between MDS and HP.

Identifiants

pubmed: 38988571
doi: 10.1016/j.heliyon.2024.e32973
pii: S2405-8440(24)09004-2
pmc: PMC11233996
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Pagination

e32973

Informations de copyright

© 2024 The Authors.

Déclaration de conflit d'intérêts

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Tsutomu Sato reports financial support, article publishing charges, and writing assistance were provided by 10.13039/501100001691Japan Society for the Promotion of Science.

Auteurs

Shohei Kikuchi (S)

Department of Hematology, Toyama University Hospital, Toyama, Japan.

Tomohiro Hayashi (T)

Department of Neurology, Toyama University Hospital, Toyama, Japan.

Honoka Nitta (H)

Department of Clinical Laboratory and Blood Center, Toyama University Hospital, Toyama, Japan.

Yusuke Kamihara (Y)

Department of Hematology, Toyama University Hospital, Toyama, Japan.

Akinori Wada (A)

Department of Hematology, Toyama University Hospital, Toyama, Japan.

Tomoki Minemura (T)

Department of Hematology, Toyama University Hospital, Toyama, Japan.

Yoshimi Nabe (Y)

Department of Hematology, Toyama University Hospital, Toyama, Japan.

Jun Murakami (J)

Division of Transfusion Medicine and Cell Therapy, Toyama University Hospital, Toyama, Japan.

Yuji Nakatsuji (Y)

Department of Neurology, Toyama University Hospital, Toyama, Japan.

Tsutomu Sato (T)

Department of Hematology, Toyama University Hospital, Toyama, Japan.

Classifications MeSH